NXGL - CONSENSUS CO - NEXGEL, Inc.

NEXGEL, Inc. (NXGL) produces advanced gel dressings, leveraging medical recognition and patent protection. The company's earnings rely on the sale of patches to retailers, with the operating margin fixed at 1.99. Leadership is driven by developments in transdermal drug delivery and polymer cross-linking. The securities price action shown below clearly demonstrates the current state of this high-tech business.

This indicator represents the weighted average target price, which converts complex DCF model calculations into a specific gap between the current quote and the asset's fundamental valuation. By analyzing the analyst consensus target for NEXGEL, Inc. (NXGL), an investor can weigh the market's growth potential against the impeccable image of NEXGEL, Inc. in the medical hydrogel production sector and the high level of trust clinics place in the safety of their products.